Andexanet Alfa News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Touching the future, to understand our present
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Touching the future, to understand our present
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca gets CDSCO nod to import and market critical anti-bleeding drug in India
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca receives CDSCO approval to market Andexanet Alfa in India for critical bleeding conditions
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
India News: AstraZeneca Pharma India has received approval for the import and marketing of Andexanet Alfa, an anticoagulant drug that addresses life-threatening bleeding associated with the use of Factor Xa inhibitors. The therapy is designed to reverse the effects of anticoagulant medications in emergency situations and has demonstrated efficacy and safety in clinical trials. The rise in the use of Factor Xa inhibitors highlights the need for a specific reversal agent to mitigate the risks of major bleeding.